David Quigley is a board director and strategic advisor who operates at the intersection of biotech, healthcare, and private equity. Currently, they serve on the Board of Directors of CervoMed, a clinical-stage biotech advancing treatments for neurodegenerative disorders, and are the Chief Investment Officer of the Anam Foundation, leading investment strategy across philanthropic initiatives. They were previously a Senior Partner Emeritus at McKinsey & Company, where they spent over 25 years advising organizations on strategy and value creation. David holds degrees from University College Dublin, Queen's University Belfast, and INSEAD. Outside of professional pursuits, they are an avid road cyclist, known for climbing Mont Ventoux annually.
This person is not in the org chart
This person is not in any teams
This person is not in any offices